Propylthiouracil Pill
PreclinicalSmall molecule
Propylthiouracil Pill is one of 8 small molecule programs targeting Thyroiditis. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Thyroiditis
#DrugCompanyPhaseTrials
1Plaquenil
Jazz PharmaceuticalsPreclinical
Potassium Iodide
MMeda Pharmaceuticals
Preclinical
Treatment as Usual
AAB Biotics, SA
Preclinical
Selenium
SSWOG Cancer Research Network
Preclinical
Methimazole Pill
FFirst Affiliated Hospital of Harbin Medical University
Preclinical
Propylthiouracil Pill
FFirst Affiliated Hospital of Harbin Medical University
Preclinical
L-Selenomethionine
SSWOG Cancer Research Network
Preclinical
Synacthen
UUniversity of Wuerzburg
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Propylthiouracil Pill. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details